# Role of Vitamin D in Osteoarthritis: Molecular, Cellular, and Clinical Perspectives

**Authors:** Thomas Mabey, Sittisak Honsawek

PMC · DOI: 10.1155/2015/383918 · 2015-07-02

## TL;DR

This paper explores the complex role of vitamin D in osteoarthritis, highlighting conflicting findings from cellular and clinical studies.

## Contribution

The paper synthesizes molecular, cellular, and clinical evidence to highlight the need for further research on vitamin D's role in osteoarthritis.

## Key findings

- Cellular studies suggest vitamin D may negatively affect osteoarthritic joints.
- Clinical research shows high vitamin D deficiency in osteoarthritis patients.
- Trials on vitamin D supplementation have produced conflicting results on pain and joint function.

## Abstract

Osteoarthritis is a debilitating and degenerative disease which affects millions of people worldwide. The causes and mechanisms of osteoarthritis remain to be fully understood. Vitamin D has been hypothesised to play essential roles in a number of diseases including osteoarthritis. Many cell types within osteoarthritic joints appear to experience negative effects often at increased sensitivity to vitamin D. These findings contrast clinical research which has identified vitamin D deficiency to have a worryingly high prevalence among osteoarthritis patients. Randomised-controlled trial is considered to be the most rigorous way of determining the effects of vitamin D supplementation on the development of osteoarthritis. Studies into the effects of low vitamin D levels on pain and joint function have to date yielded controversial results. Due to the apparent conflicting effects of vitamin D in knee osteoarthritis, further research is required to fully elucidate its role in the development and progression of the disease as well as assess the efficacy and safety of vitamin D supplementation as a therapeutic strategy.

## Linked entities

- **Diseases:** osteoarthritis (MONDO:0005178)

## Full-text entities

- **Genes:** DBP (D-box binding PAR bZIP transcription factor) [NCBI Gene 1628] {aka DABP, taxREB302}, CTSK (cathepsin K) [NCBI Gene 1513] {aka CTS02, CTSO, CTSO1, CTSO2, PKND, PYCD}, TNFRSF11B (TNF receptor superfamily member 11b) [NCBI Gene 4982] {aka OCIF, OPG, PDB5, TR1}, GC (GC vitamin D binding protein) [NCBI Gene 2638] {aka DBP, DBP-maf, DBP/GC, GRD3, Gc-MAF, GcMAF}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, MMP1 (matrix metallopeptidase 1) [NCBI Gene 4312] {aka CLG}, FGF23 (fibroblast growth factor 23) [NCBI Gene 8074] {aka ADHR, FGFN, HFTC2, HPDR2, HYPF, PHPTC}, BGLAP (bone gamma-carboxyglutamate protein) [NCBI Gene 632] {aka BGP, OC, OCN}, TNFSF11 (TNF superfamily member 11) [NCBI Gene 8600] {aka CD254, ODF, OPGL, OPTB2, RANKL, TNLG6B}, DKK1 (dickkopf Wnt signaling pathway inhibitor 1) [NCBI Gene 22943] {aka DKK-1, SK}, MMP3 (matrix metallopeptidase 3) [NCBI Gene 4314] {aka CHDS6, MMP-3, SL-1, STMY, STMY1, STR1}, VDR (vitamin D receptor) [NCBI Gene 7421] {aka NR1I1, PPP1R163}, DKK2 (dickkopf Wnt signaling pathway inhibitor 2) [NCBI Gene 27123] {aka DKK-2}, PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}, RXRA (retinoid X receptor alpha) [NCBI Gene 6256] {aka NR2B1, RXR-alpha, RXRalpha}
- **Diseases:** bone loss (MESH:D001847), hip OA (MESH:D015207), joint trauma (MESH:D014947), joint degeneration (MESH:D009410), hip (MESH:D025981), knee pain (MESH:D046788), obese (MESH:D009765), hypocalcemia (MESH:D006996), Hypovitaminosis D (MESH:D014808), OA (MESH:D010003), quadriceps dysfunction (MESH:D009135), osteoarthritic joints (MESH:D007592), fracture (MESH:D050723), degenerative disease (MESH:D019636), Osteoporosis Fractures (MESH:D010024), bone marrow lesion (MESH:D001855), ankylosing spondylitis disease (MESH:D013167), quadriceps weakness (MESH:D018908), sclerosis (MESH:D012598), osteophyte (MESH:D054850), JSN (MESH:D016893), Sclerosis of subchondral bone (MESH:D001845), RA (MESH:D001172), hypophosphatemia (MESH:D017674), BMD (MESH:D001851), Osteoporotic Fractures (MESH:D058866), weight loss (MESH:D015431), inflammation (MESH:D007249), knee OAKL (MESH:D007718), Knee OA (MESH:D020370), hypertrophy (MESH:D006984), stiffness (MESH:C566112), cartilage (MESH:D002357), Pain (MESH:D010146)
- **Chemicals:** 25(OH)D (-), 1alpha(OH)D3 (MESH:C008088), Vitamin D2 (MESH:D004872), Vit D (MESH:D014807), 25(OH)D3 (MESH:D002112), alendronate (MESH:D019386), 1,25(OH)2D3 (MESH:D002117), Ca (MESH:D002118), Previtamin D (MESH:C025168), Cholecalciferol (MESH:D002762), Pi (MESH:D010716), D (MESH:D003903), D2 (MESH:C091377), inorganic phosphate (MESH:D010710), carbon (MESH:D002244), 7-dehydrocholesterol (MESH:C016705)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC4503574/full.md

---
Source: https://tomesphere.com/paper/PMC4503574